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Abstract
Purpose Adenoid cystic carcinoma (ACC) is a rare neurotropic cancer with slow progression occurring in salivary glands 
and less frequently in other body parts. ACC is featured by hyperchromatic nuclei and various mutations in genes encod-
ing chromatin-related machineries. The ACC treatment is mainly limited to the radical surgery and radiotherapy while the 
chemotherapy remains ineffective. As the knowledge about molecular basis of ACC development is limited, we investigated 
here the molecular features of this disease.
Patients and methods This study included 50 patients with ACC. Transcript profiling of available ACC samples vs normal 
salivary gland tissue, quantitative real-time PCR (qRT-PCR) transcript level measurements and the immunohistochemistry 
(IHC) for SWI/SNF chromatin remodeling complex (CRC) subunits and androgen receptor on surgery-derived paraffin-
embedded samples were performed.
Results Transcriptomic study followed by Gene Ontology classification indicated alteration of chromatin-related processes, 
including downregulated transcript levels of main SWI/SNF CRC subunits and elevated expression of BRM ATPase-coding 
SMARCA2 gene in ACC. Subsequent IHC indicated broad accumulation of BRM ATPase and several SWI/SNF subunits, 
suggesting affected control of their protein level in ACC. The IHC revealed ectopic, heterogeneous expression of androgen 
receptor (AR) in some ACC cells.
Conclusions Our study indicated that ACC features aberrant expression of genes controlling chromatin status and structure. 
We found that the balance between SWI/SNF classes is moved towards the BRM ATPase-containing complex in ACC. As 
BRM is known to be involved in chemoresistance in cancer cells, this observation may be the likely explanation for ACC 
chemoresistance.
Keywords Adenoid cystic carcinoma · SWI/SNF complex · Androgen receptor (AR) · Progressive disease · 
Chemoresistance
Introduction
Adenoid cystic carcinoma (ACC) is an uncommon malig-
nancy. Primary lesions usually arise from salivary glands, 
more frequently from minor than major ones. Other locali-
zations include paranasal sinuses, larynx, lacrimal glands, 
bronchi, mammary and skin (Coca-Pelaz et al. 2015; Dil-
lon et al. 2016). This type of cancer most frequently occurs 
between the fourth and the sixth decades of life. ACC is 
rather indolent disease with slow growth and late develop-
ment of distant metastases, but it may also be fast-growing 
malignancy with early distant spread. When diagnosed at 
an early stage, it usually appears as a single and oval lesion 
(usually with smaller than 6 cm diameter) well defined and 
Beata Jagielska and Elzbieta Sarnowska shared first authorship.
Tomasz J. Sarnowski and Janusz A. Siedlecki contributed equally.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s0043 2-018-2783-5) contains 
supplementary material, which is available to authorized users.
 * Tomasz J. Sarnowski 
 tsarn@ibb.waw.pl
Extended author information available on the last page of the article
 Journal of Cancer Research and Clinical Oncology
1 3
partially capsulated with a pronounced tendency to aggres-
sively infiltrate surrounding tissues along nervous tissue 
structures. Metastases to regional lymph nodes and distant 
sites occur, and ACC recurrences may appear many years 
after initial treatment (van der Wal et al. 2002; Kokemu-
eller et al. 2004) although the lymph node metastases are 
uncommon (Ferlito 2016; He et al. 2017). Treatment of these 
type of cancer remains limited to surgery with or without 
adjuvant radiotherapy (proton beam) (Gentile et al. 2017). 
Moreover, no systemic treatment has been found to be effec-
tive (Laurie et al. 2011; Xu et al. 2018a). Due to peculiar 
biology of this malignancy, various attempts have been made 
including the use of metronomic chemotherapy in patients 
with advanced or disseminated disease (Visa et al. 2010; 
Caballero et al. 2013; Cassidy et al. 2018).
The ACC mutational landscape was determined and 
revealed a low exonic somatic mutation rate and wide 
mutational diversity. Among others, mutations in genes 
involved in histone acetylation/deacetylation (ARID4B, 
ARID5B, BRD1, FTSDJ1, MLL3), as well as encoding his-
tones (HIST1H2AL, HIST1H1E), were found suggesting 
that chromatin dysregulation may promote ACC develop-
ment (Ho et al. 2013). Additionally, in ACC, mutations in 
SMARCA2, a gene encoding the BRM ATPase of the SWI/
SNF chromatin remodeling complex (CRC), were found. 
Moreover, 2% of ACC cases are featured by mutations in 
ARID1A and SMARCE1 genes, coding for BAF250a and 
BAF57 non-core SWI/SNF CRC subunits, respectively, 
consistently suggesting aberrant SWI/SNF CRC function in 
ACC (Ho et al. 2013).
In this study, we attempted to better understand the 
molecular features of adenoid cystic carcinoma. The re-
analysis of available transcriptomic data followed by gene 
ontology (GO) classification indicated that ACC is featured 
by the upregulation of steroid hormone receptor activity, 
carbohydrate metabolism, cell proliferation and drug trans-
port-related processes. By contrast, the downregulated pro-
cesses were mostly related in ACC to the control of chroma-
tin structure and function including chromatin remodeling 
and organization, histone deacetylase and acetyltransferase 
complex, telomere maintenance and methyltransferase activ-
ity. Among downregulated genes, we found genes encod-
ing nearly all subunits of SWI/SNF chromatin remodeling 
complex. The subsequent immunohistochemistry (IHC) 
staining showed alterations in SWI/SNF CRC subunits’ 
abundance and ectopic expression of androgen receptor in 
ACC compared to margin tissue. Among BRM-target genes 
overexpressed in ACC, a class of genes involved in chem-
oresistance was identified. Taking together, our findings 
suggest an important role of SWI/SNF CRC impairment in 
the adenoid cystic carcinoma development and provided a 
likely explanation of the ACC resistance to various specific 
chemotherapy treatments.
Materials and methods
Patients’ characteristics
A group of 50 patients from, Marie Sklodowska-Curie 
Memorial Cancer Center and Institute of Oncology in 
Warsaw and Gliwice with diagnosed adenoid cystic car-
cinoma was subjected to this study. Primary lesions were 
most often localized in submandibular and parotid glands 
(Table 1). All 50 patients underwent primary surgical 
treatment. The patients represent whole area of Poland.
Microarray re‑analysis
Microarray datasets were obtained from Gene Expres-
sion Omnibus (GEO) database with the accession number 
GSE28996 for ACC samples and GSE36820 for normal 
salivary gland (Moskaluk et al. 2011). The nine ACC and 
three healthy salivary gland corresponding sample data 
files were re-analyzed using GeneSpring GX (Agilent) 
software according to advanced guided workflow.
Table 1  List of the most important patient characteristics in a group 
consisting of 50 ACC patients
Characteristic Number of patients (n = 50)
Gender
 Female 25 (50%)
 Male 25 (50%)
Age
 Mean age 53 (min. 22, max. 90)
 < 60 33 (66%)
 ≥ 60 17 (34%)
Localization
 Minor salivary gland 31 (62%)
 Major salivary gland 19 (38%)
pT
 pT1 6 (12%)
 pT2 19 (38%)
 pT3 3 (6%)
 pT4 11 (22%)
 n/a 11 (22%)
Treatment
 Radiotherapy 45 (90%)
 Chemotherapy 6 (12%)
Progression
 Total number 14 (28%)
 Female 5 (36%)
 Male 9 (64%)
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Immunohistochemistry
Immunohistochemical staining was performed on 4-µm FFPE 
tumor sections using the EnVision FLEX+, Mouse, High-
pH Detection System (Dako, Glostrup, Denmark). Sections 
were deparaffinized with xylene and rehydrated in ethanol 
solutions. Heat-induced epitope retrieval was carried out in 
Target Retrieval Solution (Dako) for 20 min at 96 °C. After 
cooling, the slides were treated for 5 min with an endoge-
nous peroxidase blocker (Dako), incubated with monoclonal 
antibody against androgen receptor (D6F11, Cell Signaling), 
BRG1, INI1, BAF155, BAF170, BAF250a and BRM (P680, 
D9C2, D7F8S, D8O9V, D2A8U, D9E8B, Cell Signaling) for 
30 min at room temperature, and then labeled with the EnVi-
sion FLEX+, Mouse, High-pH Detection System (Dako). The 
color reaction product was developed with 3,3′-diaminoben-
zidine tetrahydrochloride (Dako) as a substrate, and nuclear 
contrast was achieved with hematoxylin counterstaining.
Transcript level measurements
RNA was extracted from paraffin-embedded samples using 
RecoverAll™ Total Nucleic Acid Isolation Kit for FFPE 
(Invitrogen). Contamination with genomic DNA was 
removed using DNAse I treatment according to the manu-
facturer’s protocol. Aboult 300 ng of total RNA was used 
for the first-strand cDNA synthesis using Transcriptor First 
Strand Synthesis kit (ROCHE) and oligo-dT primer and ran-
dom hexamer mix. Transcript levels of studied genes were 
measured in triplicates using Applied Biosystems 7500 Fast 
device with specific primers and SybrGreen. For SMARCA2, 
following primers were used hBRMq2F: TCC GAG GCA 
AAA TCA GTC AAG and hBRMq2R: TTC CTC GAT TTG 
GCC TTT TCT. As the reference primers UBI1: ATT TGG 
GTC GCG GTT CTT G and UBI2: TGC CTT GAC ATT CTC 
GAT GGT specific for UBI (UBIQUITIN) gene were used. 
For the relative expression level calculation, the  2−ΔΔCt 
method was used.
Statistical methods
For statistical analysis, MedCalc software and GraphPad 
Prism 5.0 with Shapiro–Wilk normality test, Mann–Whitney 
rank test for independent sample and paired t test were used. 
p value < 0.05 was considered to be statistically significant.
Results
Gene expression profiling in ACC 
The adenoid cystic carcinoma is a severe disease, which 
is featured by the resistance to various treatments such as 
chemotherapy (i.e., see Visa et al. 2010; Caballero et al. 
2013; Cassidy et al. 2018) including metronomic therapy. 
Given this fact we decided to investigate the transcriptional 
profiles of ACC samples and compare them with transcript 
profiles of normal tissue to identify the molecular features 
which could be helpful in the explanation of such severe 
chemoresistancy of ACC. The reanalysis of 9 ACC vs 3 
normal salivary gland samples derived from GEO database 
(accession number GSE28996 and GSE36820) resulted in 
the identification of 8647 differentially expressed genes. 
4603 genes were downregulated in ACC samples compared 
to healthy control while 4044 genes exhibited elevated 
expression. Gene Ontology analysis showed enrichment of 
steroid hormone receptor activity, carbohydrate metabolism, 
cell proliferation and drug transport (Fig. 1a, Supplementary 
Table 1 Sub-table 1) as the most common GO processes 
upregulated in ACC. By contrast, processes downregulated 
in ACC were mostly related to the control of chromatin 
structure and functions such as chromatin remodeling, chro-
matin organization, histone deacetylase and acetyltransferase 
complex, telomere maintenance and methyltransferase activ-
ity as well as RNA splicing and mRNA splicing via spliceo-
some (Fig. 1b, Supplementary Table 1 Sub-table 2).
Aberrations of SWI/SNF complex in ACC 
In ACC, among the ‘chromatin remodeling’ GO class the 
following downregulated genes coding for various SWI/SNF 
subunits were found: SMARCB1, SMARCC1, SMARCC2 
and SMARCA4 (coding for SWI/SNF core subunits) and 
ARID1A, PBRM1, SMARCD1, SMARCD2 and SMARCE1 
(encoding non-core SWI/SNF subunits). Interestingly, the 
transcript level of SMARCA2 gene coding for the BRM 
ATPase subunit of SWI/SNF CRCs was significantly ele-
vated compared to the control tissue (Fig. 1c). Therefore, 
we employed immunohistochemistry (IHC) to investigate 
the protein level of SWI/SNF subunits such as BRM, BRG1, 
BAF155, BAF170, INI1 and BAF250a in paraffin-embedded 
ACC and healthy samples. We found that consistently with 
our transcript profiling analysis the BRM protein level was 
significantly elevated in cancer cells compared to normal 
salivary gland tissue (Fig. 2a). Surprisingly, the abundance 
of the second SWI/SNF ATPase, BRG1, did not show any 
alterations in the IHC study or was only discretely elevated 
in some ACC cells (Fig. 2b); however, the BRG1 encod-
ing SMARCA4 gene exhibited decreased transcript level in 
ACC samples. Interestingly, the protein levels of BAF155, 
BAF170 and INI1 were even higher in ACC samples than 
in healthy salivary gland tissue, although the correspond-
ing genes were downregulated at the transcript level in 
ACC samples (Fig. 2c–e). Moreover, also for BAF250a the 
slightly elevated abundance was observed in ACC (Fig. 2f).
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Furthermore, to assess if the BRM protein is ubiq-
uitously accumulated in ACC or only some regions of 
the tumor are featured by the BRM overexpression we 
performed careful inspection of all ACC samples under 
various magnifications (Fig. 3a). We found that ACC is 
featured by the general BRM over accumulation as in all 
ACC samples the ACC cells were stained independently 
on the part of the tumor (Fig. 3a). The unstained cells but 
not unstained regions were only sporadically observed in 
the case of BRM staining in ACC samples (Fig. 3b). As 
we found that ACC, a highly heterogeneous cancer type, 
is featured by the nearly homogeneous increase of BRM 
protein abundance we concluded that BRM overaccumu-
lation in most of the ACC cells may have a great impact 
on the general ACC features.
The levels of transcripts of genes coding for SWI/
SNF subunits vary between patients
More detailed analysis indicated that the SMARCA2 (BRM) 
gene expression level differs between ACC samples derived 
from various patients (Fig. 4a). Subsequent analysis of 
transcript levels of other genes encoding core SWI/SNF 
subunits such as SMARCA4(BRG1), SMARCC1(BAF155), 
SMARCC2(BAF170) and SMARCB1(INI1) indicated sim-
ilar-to-SMARCA2 variability between particular patient 
samples (Fig. 4b–e). However, the comparative analysis of 
expression levels of genes encoding core SWI/SNF subunits 
showed significant positive correlation only for SMARCA2 
and SMARCC1 genes (Fig. 4f), indicative of the occur-
rence of potential multiple mechanisms of SWI/SNF CRC 
Fig. 1  Adenoid cystic carcinoma is featured by transcriptomic 
changes affecting various regulatory pathways. a Genes upregulated 
in ACC patient samples compared to normal salivary gland and GO 
term enrichment among identified genes. b Genes downregulated in 
ACC patient samples compared to normal salivary gland, GO term 
enrichment in processes among identified genes. c Genes coding for 
SWI/SNF subunits exhibit altered transcript level in ACC samples 
compared to normal salivary gland
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impairment including its aberrant stoichiometry in ACC. 
Moreover, the careful comparison of alterations in the tran-
script level of BRM-encoding SMARCA2 gene (Fig. 5a) with 
the BRM protein abundance indicated that independently on 
the individual differences in SMARCA2 gene expression, the 
BRM protein level was always dramatically elevated sug-
gesting the existence of BRM protein stabilizing mechanism 
in the ACC cells (Fig. 5b, c).
Ectopic expression of androgen receptor features 
some ACC cells
Molecular pathway analysis using GeneSpring GX software 
showed significant differences in alpha 6 beta 4 integrin 
pathway known to be involved in epithelial cell migration 
(Mercurio et al. 2001), EGFR pathway and others mostly 
immunology-dependent pathways and androgen receptor 
(AR) pathway (Supplementary Table 2). Therefore, we 
analyzed the expression of AR in ACC samples (Fig. 6a) 
and performed the immunohistochemical study on seven 
paraffin-embedded samples using anti-BRM (Fig. 6b) and 
anti-AR (Fig. 6c) antibodies.
In three cases, the positive staining for AR was detected 
in ACC cancer cells, indicative of AR ectopic expression 
in the ACC (Fig. 6c). The subsequent comparative analysis 
indicated that the expression of SMARCA2 and SMARCB1 
genes negatively correlated with the expression of AR gene 
in the ACC samples (Fig. 6d, e).
BRM acts mostly as transcriptional repressor in ACC 
The analysis of genes directly targeted by BRM and upreg-
ulated in ACC displayed the 786 common genes. Among 
them the Gene Ontology analysis revealed the enrichment 
of cancer growth-promoting processes such as proliferation, 
intracellular transport, response to stress and chemoresist-
ance. Interestingly, the 1747 genes were found to be BRM 
dependent and downregulated in adenoid cystic carcinoma 
cells. The subsequent Gene Ontology analysis identified the 
following processes: chromatin remodeling, telomere organ-
ization, chromosome segregation and cell cycle checkpoint 
as dependent on BRM and downregulated in ACC (Fig. 7, 
Supplementary Table 1 Sub-table 3 and 4) suggesting that 
BRM acts mostly as transcriptional repressor in ACC cells.
Fig. 2  ACC cells are featured by altered abundance of SWI/SNF core and non-core subunits. IHC staining for a BRM. b BRG1. c BAF155. d 
BAF170. e INI1. f BAF250a in ACC samples compared to normal salivary gland tissue (a–f magnification: × 40)
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Discussion
Surgery with postoperative radiotherapy remains the most 
effective therapeutic modality in patients with early-stage 
head and neck adenoid cystic carcinoma (Coca-Pelaz et al. 
2015). In the case when surgery is impossible, the radio-
therapy has been used and some attempts with chemotherapy 
including metronomic therapy; however, the outcome of 
such treatments is not satisfactory (Visa et al. 2010; Cabal-
lero et al. 2013; Ko et al. 2016; Cassidy et al. 2018). As 
there is no efficient therapy for the advanced stage of the 
adenoid cystic carcinoma there was an urgent need to inves-
tigate molecular basis of this type of cancer. Therefore, we 
performed the transcript profiling analysis of nine ACC sam-
ples and three normal salivary glands from publicly avail-
able datasets. We found that more than 8600 genes were 
mis-regulated in ACC samples compared to normal sali-
vary gland tissue. 4044 of them were upregulated and 4603 
downregulated. Interestingly, the genes with downregulated 
expression in ACC samples were related to chromatin or 
chromatin involving processes such as chromatin remodeling 
and organization, histone modifications, telomere mainte-
nance as well as RNA splicing. This observation is in line 
with previous findings demonstrating that ACC is featured 
by mutations in genes coding for regulators of chromatin 
state including SMARCA2, a gene encoding BRM, the cen-
tral ATPase of SWI/SNF ATP-dependent chromatin remode-
ling complex (Ho et al. 2013). The closer inspection of SWI/
SNF CRCs revealed the mis-regulated expression of genes 
encoding its main subunits. Interestingly, almost all genes 
coding for core SWI/SNF subunits (SMARCA4, SMARCB1, 
SMARCC1, SMARCC2) as well as ARID1 and PBRM1 genes 
Fig. 3  The BRM overaccumu-
lation is a general feature of 
ACC. a Images of ACC samples 
from three different patients 
taken under three magnifica-
tions showing that strong BRM 
staining is ubiquitous and not 
restricted to ACC regions. b 
The BRM-negative staining was 
limited to sporadically observed 
single cells but not to ACC 
regions confirming ubiquitous 
BRM protein accumulation in 
ACC 
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coding for auxiliary SWI/SNF subunits were downregulated. 
Surprisingly, the expression of SMARCA2 gene encoding 
BRM ATPase was more than threefold upregulated.
As the SWI/SNF complex is composed of several subu-
nits with defined stoichiometry, the protein level analysis 
of SWI/SNF subunits in ACC samples was performed. The 
IHC analysis confirmed the general overexpression of BRM 
protein in the most of the ACC cells compared to normal sal-
ivary gland tissues. In our study, we observed sporadically 
only some BRM-unstained cells but not BRM-unstained 
regions of ACC suggesting that the BRM protein accu-
mulation is a general feature of ACC. The other SWI/SNF 
core complex subunits, namely INI1, BAF155 and BAF170 
were also overexpressed in ACC at the protein level; how-
ever, the transcript levels of genes encoding these proteins 
were significantly downregulated in ACC cancer samples. 
These findings strongly suggest that core SWI/SNF complex 
subunits are precisely regulated at the protein level. Our find-
ings suggest that in the case of adenoid cystic carcinoma the 
balance between classes of SWI/SNF complexes is shifted to 
the increased amount of BRM-containing rather than BRG1-
containing complexes. Therefore, the proper control of gene 
expression may be affected in ACC due to the alterations in 
the balance between various classes of SWI/SNF complexes. 
This could lead to the aberrant expression of various genes 
involved in cell cycle control, proliferation and cell adhe-
sion as these genes were found as targeted directly by BRM 
(Fig. 7). Additionally, the SMARCA2 gene (coding for BRM) 
was found to be mutated in 5% of ACC samples. Interest-
ingly, all mutations were located in the helicase domain of 
BRM protein (Ho et al. 2013) suggesting functional impair-
ment of the mutated protein in ACC.
The SWI/SNF complex is involved in steroid hormone 
action and directly interacts with various steroid hormone 
Fig. 4  Expression of genes coding for subunits of SWI/SNF CRCs 
varies between ACC patient-GEO database data reanalyses. a 
SMARCA2-BRM. b SMARCA4-BRG1. c SMARCC1-BAF155. 
d SMARCC2-BAF170. e SMARCB1-INI1-encoding gene tran-
script level between ACC patients samples. f Correlation between 
SMARCA2 and SMARCC1 p value 0.0339, Pearson r = 0.7049
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receptors including androgen receptor (Sarnowska et al. 
2016). The androgen receptor pathway was found as one of 
the most deregulated, with wide spectrum of AR transcript 
level in ACC patient samples. There was around ninefold 
difference between the highest and lowest AR transcript 
level in patient samples. It has been shown that AR over-
expression is most frequently associated with salivary duct 
carcinomas. In several studies, the AR positivity was shown 
in 64–77% of all salivary duct carcinoma and 5% of ACC 
cases (Dalin et al. 2017). The other study showed AR abun-
dance in about 6.6% cases of salivary gland adenoid cystic 
carcinoma (Ito et al. 2009). A number of patients with AR-
positive salivary gland carcinoma have been treated with 
anti-androgen therapy. The treatment was well tolerated, 
but relapse was commonly observed. A 3-year progression-
free survival was 12%, and a 5-year overall survival of 19% 
(Dalin et al. 2017).
Current clinical data indicate that the stage of ACC is 
the most significant factor influencing treatment outcome, 
whereas histological grade has no prognostic impact. Addi-
tionally, negative impact of vascular and neural infiltration 
on survival in male patients was shown (Spiro 1997). The 
disease is slightly more common in women (van der Wal 
et al. 2002); however, in our study, the number of women 
and men was equal. No factor has yet been shown to be 
responsible for the increased incidence of adenoid cystic 
carcinoma in female patients; however, its occurrence may 
be connected to hormones, especially that estrogen enhances 
the malignancy in ACC cells (Sumida et al. 2016).
In our study, we detected AR nuclear immunoreactiv-
ity in some examined cases. Noteworthy, the staining 
was observed in particular cancer cells only. Moreover, 
the statistically significant negative correlation between 
AR and SMARCA2(BRM) and SMARCB1(INI1) expres-
sion was found, suggesting transcriptional co-regulation 
between these genes, although further examination of the 
role of this interdependence needs to be performed. Thus, 
results presented here confirmed the hypothesis that ACC 
belongs to the most heterogeneous types of cancer and 
likely, therefore, the development of commonly used 
targeted therapy against this type of the disease is very 
difficult. Here we showed that the BRM protein is accu-
mulating in nearly all ACC cells, therefore, representing 
the most homogeneous feature of ACC which has been 
so far discovered. Moreover, large clusters of both ACC 
down- and upregulated genes represent direct BRM tar-
gets. Among common ACC upregulated and BRM target 
genes, there were identified gene classes responsible for 
Fig. 5  The SMARCA2 transcript levels vary between particular 
patients but the BRM staining always shows strong BRM overaccu-
mulation. a The relative transcript level of BRM-encoding SMARCA2 
gene varies between patients. b The immunohistochemistry staining 
of BRM protein abundance in the same patients as in a. Magnifica-
tion: × 40. c The H score analysis for patients from a, b 
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proliferation and chemoresistance processes, the two fea-
tures strictly linked to the ACC aggressiveness. These 
findings are in line with the recently published associa-
tion of BRM overexpression with the chemoresistance in 
ovarian cancer (Xu et al. 2018b). Given the observation 
that neither the regular chemotherapy nor metronomic 
one is sufficient for effective treatment of salivary gland 
ACC patients, the findings presented here may help to 
understand the molecular basis of the chemotherapy 
resistance in ACC cells and serve as solid basis for fur-
ther investigations aiming to establish new, more effective 
forms of therapy.
Fig. 6  Ectopic expression of androgen receptor features some ACC 
cells and negatively correlates to SMARCA2 and SMARCB1 genes. 
a Androgen receptor (AR) transcript level in carcinoma adenoides 
cysticum (ACC) patients. b Positive staining for AR in some cancer 
cells (indicated by red arrowhead), magnification × 40. c Correla-
tion between SMARCA2 and AR transcript, p value 0.0289, Spear-
man r = − 0.7196. d Correlation between SMARCB1 and AR p value 
0.0125, Pearson r = − 0.7832
Fig. 7  ACC is featured by affected balance between various classes of SWI/SNF CRCs
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Conclusions
So far there is no targeted therapy for treatment of patients 
with adenoid cystic carcinoma in salivary gland. Previous 
study revealed ACC as one of the most heterogeneous can-
cers with strong aberrations in pathways connected to chro-
matin and DNA stability. Our results indicated that genes 
encoding subunits of SWI/SNF chromatin remodeling com-
plex are missexpressed in ACC samples likely resulting in 
the disruption of the balance between classes of SWI/SNF 
complexes and finally leading to the global transcriptomic 
changes as well as resistance to chemotherapy. In summary, 
the findings presented here indicate an important role of 
the aberration of SWI/SNF CRCs in ACC development and 
chemoresistance and, therefore, may help to establish more 
efficient ACC-targeted therapy in the future.
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